Publications

Author Correction: Titration of RAS alters senescent state and influences tumour initiation.

Authors: ASL Chan, H Zhu, M Narita, LD Cassidy, ARJ Young, C Bermejo-Rodriguez, AT J...

Research group: Narita Group

E-pub date: 1 May 2026

Journal name: Nature

Early Radiation Therapy Response Assessment Using Multi-Scale Photoacoustic Imaging.

Authors: TL Lefebvre, M-E Oraiopoulou, EV Bunce, TR Else, LC Wright, MA Golinska, L ...

Research group: Bohndiek Group

E-pub date: 1 May 2026

Journal name: Adv Sci (Weinh)

Prevalence of clonal hematopoiesis (CH) in BRCA 1/2 mutation carriers enrolled in a randomized prevention trial of acetylsalicylic acid (ASA) – The STICS and STONES study (CCTG-OV25)

Authors: S Lheureux, S Abelson, S Bauer, M Fabre, M Bernardini, M Plante, D Provench...

Research group: Brenton Group

E-pub date: 1 May 2026

Journal name: Gynecologic Oncology

Genomic and spatial analysis of local recurrences following risk-adapted breast radiotherapy in the IMPORT trials.

Authors: SV Lightowlers, M Roman-Escorza, C Welsh, JM Bliss, JS Carroll, HYC Chan, K...

Research group: Carroll Group

E-pub date: 25 Apr 2026

Journal name: Breast Cancer Res

Imaging progenitor cell differentiation during central nervous system remyelination using an MRI gene reporter.

Authors: EES Brechbühl, MFE Hill, CZ Chen, HF Gaitsch, S Ros, L Porcu, AJ Wright, D...

Research group: Brindle Group

E-pub date: 24 Apr 2026

Journal name: Brain

WNT-driven chromosomal instability as a biomarker for PORCN inhibition

Authors: D Garcia-Lopez, A Zoufir, B Hernando, PG Santamaria, A Cadiz, H De Galard T...

Research group: Markowetz Group, Brenton Group

E-pub date: 18 Apr 2026

Journal name:

Clonal biases dictate availability of colonic cancer driver mutations for transformation.

Authors: N Skoufou-Papoutsaki, R Kemp, S Adler, K Marks, A-C Girard, S Mehmed, FC Lo...

Research group: Winton Group

E-pub date: 16 Apr 2026

Journal name: Nat Commun

Comparative ASCL1 interactome analysis reveals CDK2-Cyclin A2 as suppressors of differentiation in MYCN-amplified neuroblastoma.

Authors: L Mykhaylechko, RL Gomez, LM Woods, EK Papachristou, R Ramachandran, J Lund...

Research group: Carroll Group

E-pub date: 14 Apr 2026

Journal name: Mol Cancer Res

Filters

Research Groups

Core Facilities

Start date

End date

Author Correction: Titration of RAS alters senescent state and influences tumour initiation.

Early Radiation Therapy Response Assessment Using Multi-Scale Photoacoustic Imaging.

Prevalence of clonal hematopoiesis (CH) in BRCA 1/2 mutation carriers enrolled in a randomized prevention trial of acetylsalicylic acid (ASA) – The STICS and STONES study (CCTG-OV25)

Genomic and spatial analysis of local recurrences following risk-adapted breast radiotherapy in the IMPORT trials.

Imaging progenitor cell differentiation during central nervous system remyelination using an MRI gene reporter.

WNT-driven chromosomal instability as a biomarker for PORCN inhibition

Clonal biases dictate availability of colonic cancer driver mutations for transformation.

Comparative ASCL1 interactome analysis reveals CDK2-Cyclin A2 as suppressors of differentiation in MYCN-amplified neuroblastoma.

Themes

Filters

Research Groups

Core Facilities

Start date

End date

Author Correction: Titration of RAS alters senescent state and influences tumour initiation.

Early Radiation Therapy Response Assessment Using Multi-Scale Photoacoustic Imaging.

Prevalence of clonal hematopoiesis (CH) in BRCA 1/2 mutation carriers enrolled in a randomized prevention trial of acetylsalicylic acid (ASA) – The STICS and STONES study (CCTG-OV25)

Genomic and spatial analysis of local recurrences following risk-adapted breast radiotherapy in the IMPORT trials.

Imaging progenitor cell differentiation during central nervous system remyelination using an MRI gene reporter.

WNT-driven chromosomal instability as a biomarker for PORCN inhibition

Clonal biases dictate availability of colonic cancer driver mutations for transformation.

Comparative ASCL1 interactome analysis reveals CDK2-Cyclin A2 as suppressors of differentiation in MYCN-amplified neuroblastoma.